Factors That Influence Clinician Prescribing of Corticosteroids for Acute Idiopathic and Multiple Sclerosis–Associated Optic Neuritis: A Qualitative Study
Knowledge of risk/benefits of corticosteroids are necessary but not sufficient for evidence-based I/MS-ON practice. Variation in how clinicians treat patients with acute I/MS-ON is influenced largely by psychosocial factors, such as beliefs about corticosteroid risk/benefit trade-offs and the role of the clinician to provide treatment. Interventions to support evidence-based decision making for I/MS-ON treatment will need to provide risk/benefit information to support clinicians with varying levels of expertise, incorporate patient preference, and normalize the option to observe.
Authors
- Kevin A. Kerber (ORCID: https://orcid.org/0000-0002-4722-8307)
- Lindsey B. De Lott (ORCID: https://orcid.org/0000-0003-2403-0207)
- Timothy C. Guetterman (ORCID: https://orcid.org/0000-0002-0093-858X)
- Brian J. Zikmund‐Fisher (ORCID: https://orcid.org/0000-0002-1637-4176)
- Lizbeth A. Gonzalez
Institutions
- The Ohio State University (US)
Publication Details
- Journal
- Journal of Neuro-Ophthalmology
- Published
- 2024-08-16
- DOI
- https://doi.org/10.1097/wno.0000000000002219
- Primary Topic
- Multiple Sclerosis Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Research to Prevent Blindness
- National Eye Institute